AUPH
Aurinia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$16.08
−0.25%0
Insider buys (3m)
1
Insider sells (3m)
-$355.9K
Net value (3m)
+1.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Robertson Stephen P. · officer: Chief Legal Officer | Sale | 20,975 | $17 |
| Jun 8, 2026 | Bailey Jeffrey Allen · director | A-Award | 23,931 | $16 |
| Jun 8, 2026 | Nova Tina Susan · director | A-Award | 23,931 | $16 |
| Jun 8, 2026 | Johnson Craig A · director | A-Award | 23,931 | $16 |
| Jun 8, 2026 | Goetz Kathleen · director | A-Award | 23,931 | $16 |
| Jun 2, 2026 | TANG KEVIN · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 262,682 | $15 |
| Jun 2, 2026 | TANG KEVIN · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 343,521 | $15 |
| Jun 2, 2026 | TANG KEVIN · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 99 | $15 |
| Jun 2, 2026 | TANG KEVIN · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 206,005 | $15 |
| Jun 2, 2026 | TANG KEVIN · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 2,299 | $15 |
| May 20, 2026 | Robertson Stephen P. · officer: Chief Legal Officer | A-Award | 115,541 | $0.00 |
| May 20, 2026 | Hearne Michael S · officer: Chief Financial Officer | A-Award | 70,230 | $15 |
| May 20, 2026 | Cole Ryan · officer: Chief Operating Officer | A-Award | 116,144 | $0.00 |
| May 20, 2026 | Cole Ryan · officer: Chief Operating Officer | A-Award | 70,230 | $15 |
| May 20, 2026 | Hearne Michael S · officer: Chief Financial Officer | A-Award | 116,144 | $0.00 |
| Mar 10, 2026 | Keenan Greg · officer: SVP, Chief Medical Officer | F-InKind | 8,069 | $14 |
| Mar 3, 2026 | TANG KEVIN · director | Purchase | 83,561 | $14 |
| Mar 3, 2026 | TANG KEVIN · director | Purchase | 184,208 | $14 |
| Mar 3, 2026 | TANG KEVIN · director | Purchase | 300,000 | $14 |
| Mar 3, 2026 | TANG KEVIN · director | Purchase | 1,600 | $14 |
| Mar 3, 2026 | TANG KEVIN · director | Purchase | 214,839 | $14 |
| Mar 3, 2026 | TANG KEVIN · director | Purchase | 115,792 | $14 |
| Feb 23, 2026 | Robertson Stephen P. · officer: EVP, General Counsel | F-InKind | 34,638 | $14 |
| Feb 23, 2026 | Greenleaf Peter · director, officer: Chief Executive Officer | F-InKind | 100,171 | $14 |
| Feb 23, 2026 | Donley Matthew Maxwell · officer: Chief Operating Officer | F-InKind | 32,901 | $14 |
| Feb 23, 2026 | Miller Joseph M · officer: Chief Financial Officer | F-InKind | 32,424 | $14 |
| Feb 3, 2026 | Keenan Greg · officer: SVP, Chief Medical Officer | F-InKind | 11,552 | $15 |
| Jan 5, 2026 | Robertson Stephen P. · officer: EVP, General Counsel | F-InKind | 40,385 | $16 |
| Jan 5, 2026 | Robertson Stephen P. · officer: EVP, General Counsel | A-Award | 48,558 | $0.00 |
| Jan 5, 2026 | Donley Matthew Maxwell · officer: Chief Operating Officer | A-Award | 54,166 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 90Increased 209Reduced 155Sold out 25
| Filer | Action | Shares | Filed |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | Increased | 13,044,106 | Aug 14, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Increased | 12,229,500 | May 15, 2026 |
| BlackRock, Inc. | Increased | 8,193,085 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 7,845,521 | May 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 5,619,401 | Aug 14, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 3,969,834 | May 15, 2026 |
| NEA Management Company, LLC | Unchanged | 3,969,834 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 3,467,514 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 3,428,705 | May 15, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Reduced | 3,284,368 | May 14, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Reduced | 3,264,062 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 2,589,615 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 2,527,099 | May 15, 2026 |
| MORGAN STANLEY | Increased | 2,308,244 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 2,232,548 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026